SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe
Key Highlights
- ➤SkinStylus® now available in UK, Ireland, Germany, France, Spain and Portugal
- ➤SkinHealth Systems (SKIN) will sell directly through its European commercial organization
- ➤Distributor-market expansion is expected to begin in 2027
- ➤SkinHealth Systems acquired SkinStylus in 2023 to broaden its professional skin health portfolio
Expert Statements
Pedro Malha, President and chief executive officer of SkinHealth Systems
“Expanding SkinStylus internationally is an important step in building SkinHealth Systems into a broader medical aesthetics ecosystem.”
Pedro Malha, President and chief executive officer of SkinHealth Systems
“By leveraging the strength of the Hydrafacial device footprint and our established provider relationships, we can bring providers complementary technologies that address a wider range of cosmetic skin concerns and create more opportunities to serve their clients.”
LONG BEACH, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems (Nasdaq: SKIN), home to flagship brand Hydrafacial™, today announced the European expansion of the SkinStylus(®) SteriLock(®) MicroSystem, a professional microneedling and nano-needling device intended for cosmetic use. The device is now available in the UK, Ireland, Germany, France, Spain and Portugal.
The launch builds on growing global interest in professional microneedling and advances the SkinHealth Systems’ strategy to offer complementary solutions addressing a broad range of skin concerns, needs and treatment goals. The company will leverage Hydrafacial’s established European commercial organization and provider relationships to introduce SkinStylus to aesthetic professionals across the region.
Get started
Create a free account to read the full story.